Highlights Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Real-time Estimate Cboe BZX Other stock markets 09:44:57 2024-04-30 am EDT			5-day change	1st Jan Change
3.83 ^USD	-0.78%		+0.26%	-21.72%

Apr. 05	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	CI
Mar. 06	JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	Apr. 05	CI
Akoya Biosciences, Inc. Provides Revenue Guidance for the Full Year 2024	Mar. 04	CI
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q4 Revenue $26.5M, vs. Street Est of $26.1M	Mar. 04	MT
Akoya Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 04	CI
Akoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher Deal	Jan. 08	DJ
Akoya Biosciences Expects 20% Revenue Growth in 2024; Shares Gain Premarket	Jan. 08	MT
Akoya Biosciences Unveils Algorithm for Integration of Spatial, Single-Cell Data; Shares Jump Premarket	Jan. 08	MT
Akoya Biosciences Deploys the Maxfuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory At Stanford University for Multiomic Integration of Spatial and Single-Cell Data on the Enable Medicine Platform	Jan. 07	CI
Akoya Biosciences, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023 and for the Fiscal Year 2024	Jan. 07	CI
Akoya Biosciences, Inc. and Thermo Fisher Scientific, Inc. Announce License and Distribution Agreement to Deliver Spatial Multiomics Workflow	Jan. 07	CI
Akoya Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q3 Revenue $25.2M, vs. Street Est of $24.5M	Nov. 08	MT
Akoya Biosciences, Inc. Reiterates Revenue Guidance for the Fiscal Year 2023	Nov. 08	CI
Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023	23-10-31	CI
Akoya Biosciences, Inc. Launches PhenoCycler-Fusion 2.0 and Phenoimager HT 2.0 Platform Upgrades	23-09-19	CI
Bio-Techne Ends Collaboration Program with Akoya to Co-Develop an Automated Rnascope Workflow for Use with the Phenocycler®?-Fusion System	23-08-14	CI
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q2 Revenue $23.5M, vs. Street Est of $22.4M	23-08-07	MT
Akoya Biosciences, Inc. Provides Revenue Guidance for the Fiscal Year 2023	23-08-07	CI
Akoya Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q1 Revenue $21.4M	23-05-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Highlights

Filters